Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Pennsylvania College of Optometry |
---|---|
Information provided by: | Pennsylvania College of Optometry |
ClinicalTrials.gov Identifier: | NCT00347581 |
This study is designed to compare the use of special prism glasses to placebo treatment for children with symptomatic convergence insufficiency.
Condition | Intervention | Phase |
---|---|---|
Convergence Insufficiency |
Procedure: Base-in prism glasses for reading Procedure: Placebo reading glasses |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Randomized Clinical Trial of the Effectiveness of Base-in Prism Reading Glasses Vs. Placebo Reading Glasses for Symptomatic Convergence Insufficiency in Children |
Estimated Enrollment: | 72 |
Study Start Date: | May 2003 |
Estimated Study Completion Date: | August 2004 |
The Base-in for Convergence Insufficiency Treatment Trial (BI-CITT) is a multi-center, placebo-controlled, masked, clinical trial designed to compare the benefits of base-in prism for patients with convergence insufficiency (CI).
The goals of this clinical trial are:
Ages Eligible for Study: | 9 Years to 18 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Alabama | |
University of Alabama, Birmingham, College of Optometry | |
Birmingham, Alabama, United States, 35294 | |
United States, California | |
Southern California College of Optometry | |
Fullerton, California, United States, 92831 | |
United States, Florida | |
NOVA College of Optometry | |
Ft. Lauderdale, Florida, United States, 33328 | |
Bascom Palmer Eye Institute | |
Miami, Florida, United States, 33136 | |
United States, Indiana | |
Indiana University College of Optometry | |
Bloomington, Indiana, United States, 47405 | |
United States, New York | |
State University of New York, College of Optometry | |
New York, New York, United States, 10036 | |
United States, Ohio | |
The Ohio State University | |
Columbus, Ohio, United States, 43210 | |
The Ohio State University, Optometry Coordinating Center | |
Columbus, Ohio, United States, 43210 | |
United States, Pennsylvania | |
Eye Institute, Pennsylvania College of Optometry | |
Philadelphia, Pennsylvania, United States, 19141 | |
United States, Texas | |
University of Houston, College of Optometry | |
Houston, Texas, United States, 77204 |
Study Chair: | Mitchell Scheiman, OD | Pennsylvania College of Optometry |
Study ID Numbers: | hms0304 |
Study First Received: | July 3, 2006 |
Last Updated: | July 3, 2006 |
ClinicalTrials.gov Identifier: | NCT00347581 History of Changes |
Health Authority: | United States: Institutional Review Board |
convergence insufficiency base-in prism orthoptics vision therapy |
Dopamine Uptake Inhibitors Neurotransmitter Agents Adrenergic Agents Eye Diseases Central Nervous System Diseases Central Nervous System Stimulants Ocular Motility Disorders |
Methamphetamine Dopamine Amphetamine Dopamine Agents Peripheral Nervous System Agents Motor Neuro-ophthalmic Disorders |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Adrenergic Agents Molecular Mechanisms of Pharmacological Action Adrenergic Uptake Inhibitors Sympathomimetics Eye Diseases Nervous System Diseases Physiological Effects of Drugs Central Nervous System Diseases |
Central Nervous System Stimulants Pharmacologic Actions Ocular Motility Disorders Methamphetamine Autonomic Agents Therapeutic Uses Dopamine Agents Amphetamine Peripheral Nervous System Agents Cranial Nerve Diseases Central Nervous System Agents |